Atlas Venture Life Science Advisors, LLC

报告期 2026-03-31 · CIK 0001917529

持仓数

前50大市值合计

$790.0M

报告期

2026-03-31

前 6 大持仓

标的

类型

市值

股数

占比*

KYMR Kymera Therapeutics, Inc.

Common Stock

$381.3M

4,578,008

48.3%

DYN Dyne Therapeutics, Inc.

Common Stock

$165.5M

9,130,465

21.0%

SION Sionna Therapeutics, Inc.

Common Stock

$120.1M

2,995,602

15.2%

IRON Disc Medicine, Inc.

Common Stock

$96.8M

1,513,875

12.3%

QTTB Q32 Bio, Inc.

Common Stock

$13.4M

2,092,106

1.7%

KRRO Korro Bio, Inc.

Common Stock

$12.9M

1,137,149

1.6%

* 占比按本页前 50 大持仓市值合计计算

持仓集中度按前 50 大市值

100%前 6 大占比

KYMR48.3%DYN21.0%SION15.2%IRON12.3%QTTB1.7%KRRO1.6%其他0.0%